Related Experiment Video
Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
The effect of cholesterol reduction with cholestyramine on renal function
Abhijit V Kshirsagar1, David A Shoham, Heejung Bang
1University of North Carolina Kidney Center, Chapel Hill, NC, USA. sagar@med.unc.edu
Cholesterol reduction using cholestyramine did not significantly improve kidney function in healthy men. Further research is needed to confirm if lowering cholesterol benefits kidney health.
Area of Science:
- Cardiovascular Health
- Nephrology
- Pharmacology
Background:
- Dyslipidemia is a known risk factor for kidney insufficiency.
- Limited data exist on cholesterol reduction's impact on kidney function in healthy individuals.
Purpose of the Study:
- To investigate the effect of cholestyramine on renal function in middle-aged men.
- Secondary analysis of the Lipid Research Clinics Coronary Primary Prevention Trial.
Main Methods:
- 3,603 middle-aged men were analyzed.
- 1,806 received cholestyramine, 1,797 received placebo.
- Glomerular filtration rate (GFR) was the primary outcome measure.
Main Results:
- No significant difference in GFR was observed between cholestyramine and placebo groups.
- Mean GFR difference was 0.39 mL/min/1.73 m2 over 8 years (P=0.28).
Conclusions:
- Cholestyramine treatment did not meaningfully impact renal function compared to placebo.
- Further intervention trials are necessary to confirm benefits of cholesterol reduction on kidney function.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

